Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday

Raymond James raised the price target for Jabil Inc. JBL from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on Monday.
Canaccord Genuity boosted the price target for ACADIA Pharmaceuticals Inc. ACAD from $24 to $26. Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating. ACADIA Pharmaceuticals shares fell 4.7% to close at $19.41 on Monday.
JMP Securities cut the price target for Oportun Financial Corporation OPRT from $11 to $6. JMP Securities analyst David Scharf Sommer maintained a Market Outperform rating. Oportun Financial shares fell 2.6% to $4.08 in pre-market trading.
Raymond James raised e.l.f. Beauty, Inc. ELF price target from $75 to $80. Raymond James analyst Olivia Tong maintained an Outperform rating. e.l.f. Beauty shares gained 0.1% to close at $69.58 on Monday.
Citigroup raised Amylyx Pharmaceuticals, Inc. AMLX price target from $51 to $54. Citigroup analyst Itay Michaeli maintained a Buy rating. Amylyx Pharmaceuticals shares gained 17% to $36.45 in pre-market trading.
Needham raised the price target for Cellebrite DI Ltd. CLBT from $6.5 to $7. Needham analyst Mike Cikos maintained a Buy rating on the stock. Cellebrite DI shares fell 0.9% to close at $5.82 on Monday.
HSBC lowered Lufax Holding Ltd LU price target from $4 to $3. HSBC analyst Carson Lo maintained a Buy rating. Lufax Holding shares fell 0.5% to $1.91 in pre-market trading.
Barclays raised NIKE, Inc. NKE price target from $109 to $110. Barclays analyst Jiong Shao maintained an Equal-Weight rating. NIKE shares rose 0.5% to $117.45 in pre-market trading
Telsey Advisory Group cut Williams-Sonoma, Inc. WSM price target from $155 to $142. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Williams-Sonoma shares rose 0.6% to $118.98 in pre-market trading.
BMO Capital raised Seagen Inc. SGEN price target from $179 to $229. BMO Capital analyst Etzer Darout downgraded the stock from Outperform to Market Perform. Seagen shares rose 0.8% to $199.30 in pre-market trading.
RBC Capital cut Huntington Bancshares Incorporated HBAN price target $18 to $16. RBC Capital analyst Jon Arfstrom maintained an Outperform rating. Huntington Bancshares shares fell 16.8% to close at $11.12 on Monday.